Liver Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), By Disease (NAFLD, NASH, Fibrosis, Cirrhosis), By End-use (Hospitals, Laboratories), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Lip Powder Market Growth & Trends
The global lip powder market size is expected to reach USD 734.1 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.6% over the forecast period. Growing demand for matte finish lightweight lip color is fueling the demand for the product. Over the past few years, consumers of the makeup industry has been experimenting with new makeup products. Therefore, the lip powder products have gained significant popularity in the makeup industry. Furthermore, rapidly growing social media has been influencing the consumers to try new products.
The palette product segment dominated the market in 2023. Palettes include a balm in the lip kit, along with a powder color. Consumers prefer this kit as the balm keeps the skin hydrate. However, pens are easy to apply and more handy than the palette. Therefore, pens are expected to witness the fastest growth in the near future.
In terms of distribution channel, the online segment is expected to witness significant growth in the projected period. Rapid penetration of internet users has increased the online sales of the product. Moreover, increasing number of online retailers across the globe has made the product easily available to the consumers. As a result, consumer preference is shifting towards online shopping from the traditional brick and mortar shopping.
As of 2023, Asia Pacific held the largest market share. Rising concerns over physical appearance among working women have fueled the market growth in this region. In addition, increasing spending on personal grooming products in the developing countries including China, South Korea, Indonesia, Philippines, India, Taiwan, and Malaysia is boosting the demand for the product.
Key competitors of this industry include L'Orйal S.A.; The Estйe Lauder Companies Inc.; Shiseido Company; Revlon, Inc.; BY TERRY; Stellar Beauty; Urban Decay; CLE COSMETICS; CHANEL International B.V.; and Sephora USA, Inc.
Over the past few years, leading manufacturers of the cosmetics industry are entering the market to meet the growing demand for the product. For instance, in 2018, CHANEL International B.V. launched Poudre ? L?vres Lip Balm and Powder Duo. It contains both balm and powder in the palette format, which is available in three different shades.
Lip Powder Market Report Highlights
Lip Powder Market Growth & Trends
The global lip powder market size is expected to reach USD 734.1 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.6% over the forecast period. Growing demand for matte finish lightweight lip color is fueling the demand for the product. Over the past few years, consumers of the makeup industry has been experimenting with new makeup products. Therefore, the lip powder products have gained significant popularity in the makeup industry. Furthermore, rapidly growing social media has been influencing the consumers to try new products.
The palette product segment dominated the market in 2023. Palettes include a balm in the lip kit, along with a powder color. Consumers prefer this kit as the balm keeps the skin hydrate. However, pens are easy to apply and more handy than the palette. Therefore, pens are expected to witness the fastest growth in the near future.
In terms of distribution channel, the online segment is expected to witness significant growth in the projected period. Rapid penetration of internet users has increased the online sales of the product. Moreover, increasing number of online retailers across the globe has made the product easily available to the consumers. As a result, consumer preference is shifting towards online shopping from the traditional brick and mortar shopping.
As of 2023, Asia Pacific held the largest market share. Rising concerns over physical appearance among working women have fueled the market growth in this region. In addition, increasing spending on personal grooming products in the developing countries including China, South Korea, Indonesia, Philippines, India, Taiwan, and Malaysia is boosting the demand for the product.
Key competitors of this industry include L'Orйal S.A.; The Estйe Lauder Companies Inc.; Shiseido Company; Revlon, Inc.; BY TERRY; Stellar Beauty; Urban Decay; CLE COSMETICS; CHANEL International B.V.; and Sephora USA, Inc.
Over the past few years, leading manufacturers of the cosmetics industry are entering the market to meet the growing demand for the product. For instance, in 2018, CHANEL International B.V. launched Poudre ? L?vres Lip Balm and Powder Duo. It contains both balm and powder in the palette format, which is available in three different shades.
Lip Powder Market Report Highlights
- Asia Pacific held the largest lip powder market share of 29.5% in 2023
- North America lip powder market is anticipated to experience the fastest CAGR during the forecast period.
- The palette product segment dominated the market in 2023 and accounted for 53.4% share of the overall revenue
- The offline distribution segment dominated the market in 2023. The growth is attributed to rise in number of brick-and-mortar specialty stores.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Diagnosis Technique Segment
1.2.2. Disease Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising Prevalence of Liver Diseases
3.2.1.2. Advancements in Diagnostic Technologies
3.2.1.3. Increasing Awareness and Early Detection
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Advanced Diagnostics
3.2.2.2. Limited Awareness in Developing Regions
3.2.3. Market opportunity analysis
3.3. Global Liver Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: DIAGNOSIS TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Liver Disease Diagnostics Market Diagnosis Technique Movement Analysis
4.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Diagnosis Technique, 2018 to 2030 (USD Million)
4.4. Imaging
4.4.1. Imaging market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Laboratory Tests
4.5.1. Laboratory Tests market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Endoscopy
4.6.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Biopsy
4.7.1. Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: DISEASE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Liver Disease Diagnostics Market Disease Movement Analysis
5.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
5.4. NAFLD
5.4.1. NAFLD market estimates and forecasts 2018 to 2030 (USD Million)
5.5. NASH
5.5.1. NASH market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Fibrosis
5.6.1. Fibrosis market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Cirrhosis
5.7.1. Cirrhosis market estimates and forecasts 2018 to 2030 (USD Million)
5.8. HCC
5.8.1. HCC market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Liver Disease Diagnostics Market End Use Movement Analysis
6.2.1. Global Liver Disease Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Laboratories
6.4.1. Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. LIVER DISEASE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2023
8.4. List of Key Certification Providers/Scheme Owners
8.5. Company Profiles/Listing
8.5.1. Abbott
8.5.1.1. Company overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. F. Hoffmann-La Roche Ltd.
8.5.2.1. Company overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Thermo Fisher Scientific Inc.
8.5.3.1. Company overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Randox Laboratories Ltd
8.5.4.1. Company overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Boston Scientific Corporation
8.5.5.1. Company overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. Laboratory Corporation of America Holdings
8.5.6.1. Company overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Fujifilm Corporation
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Horiba Medical
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Siemens Healthcare GmbH
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Quest Diagnostics
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Diagnosis Technique Segment
1.2.2. Disease Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective
1.10.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
CHAPTER 3. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising Prevalence of Liver Diseases
3.2.1.2. Advancements in Diagnostic Technologies
3.2.1.3. Increasing Awareness and Early Detection
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Advanced Diagnostics
3.2.2.2. Limited Awareness in Developing Regions
3.2.3. Market opportunity analysis
3.3. Global Liver Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
CHAPTER 4. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: DIAGNOSIS TECHNIQUE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global Liver Disease Diagnostics Market Diagnosis Technique Movement Analysis
4.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Diagnosis Technique, 2018 to 2030 (USD Million)
4.4. Imaging
4.4.1. Imaging market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Laboratory Tests
4.5.1. Laboratory Tests market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Endoscopy
4.6.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Biopsy
4.7.1. Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: DISEASE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global Liver Disease Diagnostics Market Disease Movement Analysis
5.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
5.4. NAFLD
5.4.1. NAFLD market estimates and forecasts 2018 to 2030 (USD Million)
5.5. NASH
5.5.1. NASH market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Fibrosis
5.6.1. Fibrosis market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Cirrhosis
5.7.1. Cirrhosis market estimates and forecasts 2018 to 2030 (USD Million)
5.8. HCC
5.8.1. HCC market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Global Liver Disease Diagnostics Market End Use Movement Analysis
6.2.1. Global Liver Disease Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Laboratories
6.4.1. Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. LIVER DISEASE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2023
8.4. List of Key Certification Providers/Scheme Owners
8.5. Company Profiles/Listing
8.5.1. Abbott
8.5.1.1. Company overview
8.5.1.2. Financial performance
8.5.1.3. Product benchmarking
8.5.1.4. Strategic initiatives
8.5.2. F. Hoffmann-La Roche Ltd.
8.5.2.1. Company overview
8.5.2.2. Financial performance
8.5.2.3. Product benchmarking
8.5.2.4. Strategic initiatives
8.5.3. Thermo Fisher Scientific Inc.
8.5.3.1. Company overview
8.5.3.2. Financial performance
8.5.3.3. Product benchmarking
8.5.3.4. Strategic initiatives
8.5.4. Randox Laboratories Ltd
8.5.4.1. Company overview
8.5.4.2. Financial performance
8.5.4.3. Product benchmarking
8.5.4.4. Strategic initiatives
8.5.5. Boston Scientific Corporation
8.5.5.1. Company overview
8.5.5.2. Financial performance
8.5.5.3. Product benchmarking
8.5.5.4. Strategic initiatives
8.5.6. Laboratory Corporation of America Holdings
8.5.6.1. Company overview
8.5.6.2. Financial performance
8.5.6.3. Product benchmarking
8.5.6.4. Strategic initiatives
8.5.7. Fujifilm Corporation
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Horiba Medical
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. Siemens Healthcare GmbH
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Quest Diagnostics
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
